Starling Oncology
STLN
6.43
-0.15
-2.28%
Starling Oncology
US · STLN
#3565 by market cap
6.43
-0.15
-2.28%
Live - 5344 symbols - heartbeat 269s ago
· 2026-10-08 09:13
Pre-market
6.41
-0.31%
After-hours
6.43
0.00%
- Market cap
- 655.32M
- P/E (TTM)i
- -22.17
- P/Bi
- -26.35
- EPSi
- -0.54
- Div yieldi
- 0.00%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on STLN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.5 percentage points.
Institutional ownership
- Held by institutions
- 48.09% +0.48pp
- Institutions
- 149 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund23.21%
Hedge Fund14.72%
Individual/Insider12.78%
VC/PE Fund3.58%
Family Office/Trust2.49%
Public Company1.49%
Private Company1.30%
Insurance Company1.19%
Other39.17%
Top holders as of 2026-08-14
Jorey Chernett
10.46% · 10.66M sh
BlackRock
4.66% · 4.75M sh
Vanguard Capital Management, LLC
3.70% · 3.77M sh
M33 Growth, LLC
3.58% · 3.64M sh
Parian Global Management LP
3.49% · 3.55M sh
Deerfield Management Company, L.P.
3.30% · 3.36M sh
Josh Arnold Investment Consultant, LLC
2.42% · 2.46M sh
Geode Capital Management, LLC
1.86% · 1.90M sh
Wexford Capital LP
1.68% · 1.71M sh
State Street Global Advisors
1.52% · 1.55M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Jorey Chernett | -- | 10.46% |
| Daniel Virnich | Chief Executive Officer | 0.70% |
| Bradford Hively | Vice Chairperson | 0.31% |
| Anne McGeorge | Independent Director | 0.29% |
| Karen Marie Johnson | Independent Director | 0.28% |
| Mark Pacala | Independent Director | 0.25% |
| Mohit Kaushal | Independent Director | 0.17% |
| Kristin England | Chief Administrative Officer | 0.10% |
| Jeffrey Langsam | -- | 0.06% |
| Robert Carter | Officer | 0.05% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-20 | Bradford Hively | Vice Chairperson | Open Market Disposition | -298,853 | $6.51 |
| 2026-08-13 | Jorey Chernett | -- | Open Market Acquisition | +12,000 | $6.54 |
| 2026-08-12 | Jorey Chernett | -- | Open Market Derivative Dispositi | -100 | $9.00 |
| 2026-07-26 | Mark Pacala | Independent Director | Other Acquisition | +30,120 | -- |
| 2026-07-26 | Mark Stolper | Director | Other Acquisition | +31,124 | -- |
| 2026-07-26 | Bradford Hively | Vice Chairperson | Other Acquisition | +27,108 | -- |
| 2026-07-26 | Anne McGeorge | Independent Director | Other Acquisition | +41,165 | -- |
| 2026-07-26 | Mohit Kaushal | Independent Director | Other Acquisition | +33,133 | -- |
| 2026-07-26 | Kimberly Commins-Tzoumakas | Director | Other Acquisition | +29,116 | -- |
| 2026-07-26 | Karen Marie Johnson | Independent Director | Other Acquisition | +31,124 | -- |
| 2026-07-20 | Jorey Chernett | -- | Open Market Acquisition | +18,000 | $5.27 |
| 2026-07-13 | Yale Podnos | Chief Medical Officer & President of Practice | Derivative Exercise and Sale | -23,452 | $1.87–6.43 |
| 2026-07-09 | Jorey Chernett | -- | Open Market Acquisition | +15,000 | $5.85 |
| 2026-07-06 | Mark Stolper | Director | Other Acquisition | +25,833 | -- |
| 2026-07-06 | Kimberly Commins-Tzoumakas | Director | Other Acquisition | +17,185 | -- |
| 2026-06-22 | Jorey Chernett | -- | Open Market Acquisition | +18,000 | $5.02 |
| 2026-06-07 | Yale Podnos | Chief Medical Officer & President of Practice | Automatic Disposition | -23,451 | $5.38 |
| 2026-06-03 | Jorey Chernett | -- | Open Market Acquisition | +12,000 | $4.75 |
| 2026-05-20 | Daniel Virnich | Chief Executive Officer | Other Disposition | -23,058 | $4.47 |
| 2026-05-20 | Yale Podnos | Chief Medical Officer & President of Practice | Other Disposition | -1,805 | $4.47 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:13:48 · For reference only, not investment advice and not tailored to your situation.